prostate cancer

23andMe Keeps Snagging FDA Nods for Cancer Marker Tests
Medical Devices and Diagnostics Industry
Tue, 01/11/22 - 10:15 pm
23andMe
FDA
diagnostics
prostate cancer
cancer
Dendreon ups its Provenge marketing game with help from NBA all-star Grant Hill
Fierce Pharma
Tue, 12/7/21 - 11:41 pm
Dendreon
Provenge
pharma marketing
prostate cancer
celebrity endorsements
Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer
Pharmaforum
Fri, 12/3/21 - 10:33 am
Bayer
Nubeqa
castration-resistant prostate cancer
prostate cancer
clinical trials
Promising Signals Emerge from Two Phase II Cancer Studies
BioSpace
Mon, 11/29/21 - 11:10 pm
clinical trials
cancer
Tetra Bio-Pharma
cancer pain
Starpharma
cabazitaxel
prostate cancer
PROpel study backs Lynparza combo in first-line prostate cancer
Pharmaforum
Fri, 09/24/21 - 11:06 am
AstraZeneca
Merck
Lynparza
clinical trials
prostate cancer
Memorial Sloan Kettering spinout gets first FDA clearance for AI to detect prostate cancer
MedCity News
Thu, 09/23/21 - 10:32 pm
FDA
Paige
Memorial Sloan Kettering
artificial intelligence
diagnostics
prostate cancer
layoffs
ESMO: Exelixis lays out promising early Cabometyx combo data in prostate cancer, but key discrepancies persist
Fierce Pharma
Sat, 09/18/21 - 08:27 pm
ESMO
Exelixis
Cabometyx
Roche
Tecentriq
clinical trials
prostate cancer
ESMO: Pfizer, Astellas' latest Xtandi survival data may shore up prostate cancer lead over J&J
Fierce Pharma
Sat, 09/18/21 - 08:26 pm
ESMO
Pfizer
Astellas
Xtandi
prostate cancer
clinical trials
ESMO: Novartis links prostate cancer drug to improved pain, quality of life as regulatory filings near
Fierce Biotech
Thu, 09/16/21 - 11:04 pm
Novartis
ESMO
clinical trials
prostate cancer
'We're Not Gonna Take It'—Bayer and Twisted Sister rocker join nonprofit to push back on prostate cancer
Fierce Pharma
Fri, 06/18/21 - 10:10 am
Bayer
pharma marketing
prostate cancer
Novartis Breaks Through with Radioligand Therapy for Prostate Cancer
BioSpace
Fri, 06/4/21 - 10:36 am
ASCO 2021
prostate cancer
radioligand
Analysts throw cold water on Exelixis and Roche's prostate cancer data, putting the pair a further step behind Novartis
Endpoints
Tue, 05/25/21 - 11:08 am
Exelixis
Cabometyx
Roche
Tecentriq
prostate cancer
AI-Enabled Prostate Cancer Therapy Wins Breakthrough Designation Courtesy of Avenda Health
Medical Devices and Diagnostics Industry
Tue, 05/11/21 - 10:20 pm
Avenda Health
artificial intelligence
devices
prostate cancer
Macrogenics takes another shot at a novel immune checkpoint
EP Vantage
Thu, 04/22/21 - 10:49 am
Macrogenics
MGC018
orlotamab
enoblituzumab
prostate cancer
metastatic castration-resistant prostate cancer
J&J decides against Erleada+Zytiga combination prostate cancer filing
Pharmaforum
Tue, 04/20/21 - 11:02 am
JNJ
prostate cancer
Erleada
Zytiga
clinical trials
Novartis' radioligand hits goal in phase 3 prostate cancer trial
Fierce Biotech
Tue, 03/23/21 - 10:29 am
Novartis
radioligand
177Lu-MSMA-617
prostate cancer
clinical trials
AstraZeneca drops breast, prostate cancer programs in Q4 pipeline cull
Fierce Biotech
Thu, 02/11/21 - 10:34 am
AstraZeneca
oncology
AZD9496
breast cancer
imaradenant
prostate cancer
Janssen Shows 35% Drop in Mortality with Prostate Cancer Drug
BioSpace
Wed, 02/10/21 - 12:01 am
Janssen
JNJ
Erleada
prostate cancer
clinical trials
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
Motley Fool
Tue, 12/29/20 - 10:57 am
Merck
AstraZeneca
Japan
ovarian cancer
prostate cancer
pancreatic cancer
Lynparza
Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug
TheStreet.com
Mon, 12/28/20 - 10:42 am
Myovant
Pfizer
prostate cancer
Orgovyx
Relugolix

Pages